NeuroClimax Gold (Max) - One month supply - Supports peak mental energy and acuity while helping combat brain fog.

NeuroClimax Gold™ (Max): intendend for maximum brain energy and mental acuity.

This is  a cutting-edge intranasal formulation that contains up to three active ingredients that are delivered to the brain with  high efficiency, intended for maximum brain energy, and brain wellness 

The Science Behind NeuroClimax Gold™

Aging, chronic stress, oxidative stress, and impaired mitochondrial function can affect the brain’s ability to maintain optimal cellular energy production, potentially contributing to mental fatigue, brain fog, and changes in cognitive performance.

One important component of healthy brain function is brain-derived neurotrophic factor (BDNF), a neurotrophic protein involved in neuronal survival, synaptic plasticity, learning, and memory. Preclinical and clinical research has associated alterations in BDNF signaling, mitochondrial function, and oxidative stress with age-related changes in neuronal function and cognitive health [Costa et al., 2015; Dagda & Das Banerjee, 2015].

The Science Behind NeuroClimax Gold™ (Max)

NeuroClimax Gold™ is a proprietary intranasal nootropic formulation combining three active compounds selected to support pathways associated with neuronal function, mitochondrial health, synaptic plasticity, memory, and mental performance.

The formulation contains the following key active ingredients:

1. Kinetin
Kinetin has been investigated as an activator of the mitochondrial protein PINK1, an important regulator of mitochondrial quality control and neuronal survival. Preclinical studies suggest that modulation of PINK1-dependent signaling may support mitochondrial function and neuronal pathways associated with BDNF expression and synaptic plasticity [Hertz et al., 2013; Soman et al., 2021].

2. Noopept
Noopept is a nootropic compound (a di-peptide) that has been studied for its potential effects on learning, memory, synaptic plasticity, and neurotrophic signaling. Preclinical studies suggest that its actions may involve pathways associated with neurotrophin signaling and glutamatergic neurotransmission [Ostrovskaya et al., 2008].

3. Centrophenoxine
Centrophenoxine has been investigated for its potential effects on cholinergic function, cellular metabolism, memory, and cognitive performance. Clinical and experimental studies have examined its ability to support cognitive function, particularly in aging populations [Marcer & Hopkins, 1977].

Why Intranasal Delivery?

Intranasal administration provides an alternative route of delivery for compounds intended to act within the central nervous system. This approach may help avoid some limitations associated with gastrointestinal degradation and first-pass metabolism following oral administration.

NeuroClimax Gold™ combines three active ingredients with pharmaceutical-grade excipients designed to support formulation stability, solubilization, sterility, and intranasal administration. These components include appropriate soothing agents, emulsifying agents, preservatives, and cyclodextrins.

Potential Benefits

Based on the known biological activities of its individual ingredients and supporting preclinical research, NeuroClimax Gold™ is formulated to:

• Support BDNF-related signaling pathways involved in neuroplasticity and neuronal function.

• Support mitochondrial function and cellular energy metabolism.

• Promote mental focus, memory, and cognitive performance.

• Support neuronal defenses against oxidative stress associated with aging and metabolic stress.

• Provide an intranasal delivery platform designed for efficient administration of its active ingredients.

Features

• Formulated to support mental clarity and help reduce feelings of mental fatigue.

• Designed to support healthy cognitive function during aging.

• Formulated to promote focus, memory, productivity, and cognitive performance.

• Combines three complementary nootropic compounds in a proprietary intranasal formulation.

• Manufactured under controlled sterile cleanroom conditions.

References

Costa, A., et al. Frontiers in Behavioral Neuroscience. 2015;9:253.

Dagda, R.K., & Das Banerjee, T. Reviews in the Neurosciences. 2015;26(3):359–370.

Hertz, N.T., et al. Cell. 2013;154(4):737–747.

Soman, S.K., et al. Journal of Neuroscience Research. 2021;99(9):2134–2155.

Ostrovskaya, R.U., et al. Bulletin of Experimental Biology and Medicine. 2008;146(3):334–337.

Marcer, D., & Hopkins, S.M. Age and Ageing. 1977;6(2):123–131.

More Information

https://www.cnscurative.com

https://www.cnscurative.store

Intellectual Property

U.S. Provisional Patent Application No. 63/897,520

Title: Treatment of Cognitive Decline and Fatigue With Intranasal Nootropic Formulations

First Named Inventor: Raul Y. Dagda

Applicant/Assignee: CNS Curative Technologies LLC

Reference: FHW081752

Manufactured by CNS Curative Technologies LLC

NeuroClimax™ nootropic formulation spray products are manufactured by CNS Curative Technologies LLC in ISO 5-certified sterile cleanroom facilities.

CNS Curative Technologies LLC
300 East 2nd Street
15th Floor, Suite 1512
Reno, Nevada 89501
USA

Phone: 775-376-0613
Email: contact@cnscurative.com

NeuroClimax™ is a trademark of CNS Curative Technologies LLC.

The statements regarding NeuroClimax Gold™ and its individual ingredients are based on published scientific literature and preclinical research unless otherwise indicated. The biological effects reported for individual ingredients do not necessarily establish clinical efficacy of the finished NeuroClimax Gold™ formulation.